Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Kara M Ruicci
Affiliation
Schulich School of Medicine and Dentistry, Western University
ORCID
Career Start Year
2017
Papers
13
H Index
9
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
34166118
Aesthetic Reconstruction of the Gauge Earlobe: Surgical Technique and Case Series.
Facial Plast Surg Aesthet Med
2022
32970704
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models.
PLoS One
2020
31864959
Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer.
Oral Oncol
2020
31804024
Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition.
Mol Oncol
2020
33059733
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.
J Exp Clin Cancer Res
2020
30468243
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth.
Int J Cancer
2019
31844556
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.
Cancers Head Neck
2019
31393061
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition.
Mol Oncol
2019
30626742
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.
JCI Insight
2019
30419054
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models.
PLoS One
2018
29899842
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines.
Oncotarget
2018
30115483
ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
Oral Oncol
2018
29069723
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer.
Oncotarget
2017
1 - 13 of 13
Column Actions
Search
Recommended Authors
Hua Li
University of California san francisco
Career Start Year
2013
Number of shared co-authors
0
Shuling Ren
Beijing Friendship Hospital, Capital Medical University
Career Start Year
2013
Number of shared co-authors
0
Stefan Hartmann
University Hospital Wurzburg
Career Start Year
2013
Number of shared co-authors
0
Takahito Fukusumi
Osaka University Graduate School of Medicine
Career Start Year
2012
Number of shared co-authors
0
Shilpa Bhatia
University of Colorado Denver at Anschutz Medical Campus
Career Start Year
2011
Number of shared co-authors
0
Toni M Brand
University of Wisconsin School of Medicine and Public Health
Career Start Year
2011
Number of shared co-authors
0
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2010
Number of shared co-authors
5
Alan L Ho
Memorial Sloan Kettering Cancer Center
Career Start Year
2009
Number of shared co-authors
1
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Career Start Year
2008
Number of shared co-authors
0
Juan L Callejas-Valera
Cancer Biology Research Center
Career Start Year
2008
Number of shared co-authors
0
Julie E Bauman
George Washington University
Career Start Year
2007
Number of shared co-authors
0
Neil E Bhola
Zai Lab (US) LLC
Career Start Year
2006
Number of shared co-authors
0
Stephen B Keysar
University of Colorado Denver
Career Start Year
2006
Number of shared co-authors
0
Sabrina Daniela da Silva
Jewish General Hospital
Career Start Year
2004
Number of shared co-authors
14
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year
2002
Number of shared co-authors
3
Ezra E W Cohen
university of california san diego Health System
Career Start Year
2001
Number of shared co-authors
1
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year
2001
Number of shared co-authors
1
Hyunseok Kang
Johns Hopkins University
Career Start Year
2000
Number of shared co-authors
0
Sana D Karam
University of Colorado School of Medicine
Career Start Year
2000
Number of shared co-authors
0
Rifat Hasina
University of Chicago Medicine
Career Start Year
1999
Number of shared co-authors
0
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year
1996
Number of shared co-authors
0
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
0
Mitchell J Frederick
Baylor College of Medicine
Career Start Year
1995
Number of shared co-authors
0
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year
1988
Number of shared co-authors
2
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
1
Jennifer R Grandis
University of California san francisco
Career Start Year
1988
Number of shared co-authors
0
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year
1987
Number of shared co-authors
1
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year
1987
Number of shared co-authors
14
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year
1986
Number of shared co-authors
1
Carter Van Waes
National Institute of Deafness and Other Communication Disorders
Career Start Year
1984
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
John W Barrett
University of Western Ontario
Co-authored papers
12
Stephanie Danielle MacNeil
Schulich School of Medicine and Dentistry, Western University
Co-authored papers
12
Joe S Mymryk
University of Western Ontario
Co-authored papers
12
John Yoo
Schulich School of Medicine & Dentistry, Western University
Co-authored papers
12
Nicole Pinto
School of Public Policy at the University of Calgary
Co-authored papers
12
Anthony C Nichols
University of Western Ontario
Co-authored papers
12
Kevin Fung
Schulich School of Medicine & Dentistry, Western University, Victoria Hospital
Co-authored papers
12
Paul C Boutros
University of California los angeles
Co-authored papers
9
Christopher J Howlett
Western University
Co-authored papers
6
William Stecho
University of Western Ontario
Co-authored papers
6
Farhad Ghasemi
Western University
Co-authored papers
6
David A Palma
University of Western Ontario
Co-authored papers
5
Laurie Ailles
University of Toronto
Co-authored papers
5
Alessandro Datti
University of Perugia
Co-authored papers
5
Paul Plantinga
University of Western Ontario
Co-authored papers
5
Eric Winquist
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers
5
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
Stephenie D Prokopec
University Health Network
Co-authored papers
4
Neil Mundi
Southern Illinois University School of Medicine
Co-authored papers
3
Mohammad Imran Khan
King Abdulaziz University (KAU), King Abdulaziz University
Co-authored papers
3
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Co-authored papers
3
Ren X Sun
Ontario Institute for Cancer Research, University of Toronto
Co-authored papers
3
Morgan Black
Schulich School of Medicine and Dentistry, Western University
Co-authored papers
3
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Co-authored papers
3
Axel Sahovaler
Schulich School of Medicine & Dentistry, Western University
Co-authored papers
2
Hon S Leong
University of Toronto
Co-authored papers
2
Matthew R Lowerison
University of Illinois at Urbana-Champaign
Co-authored papers
2
Sandeep Dhaliwal
University of California at Davis School of Medicine
Co-authored papers
2
Krupal B Patel
Moffitt Cancer Center
Co-authored papers
2
Andrew Warner
Western University and London Regional Cancer Program
Co-authored papers
1
1 - 30